Gabelli On DBD Q1 Results

Gabelli & Company has issued a report regarding the 1Q11 results from Diebold Inc DBD. Gabelli writes, "EPS of 23 cents vs. 34 cents... Revenue down 1%, driven by a weaker than expected Europe offset by an accelerating North America." DBD is Buy rated and closed at $34.01 a share yesterday.